Covid-19 roundup: Pfizer and Moderna won't attend White House's 'Vaccine Summit' — report; Sinovac clarifies efficacy numbers
Though the White House is planning on hosting a “Vaccine Summit” on Tuesday, two major players will not be attending.
Pfizer and Moderna have both reportedly declined invitations to the event, according to STAT News, a move coming after Pfizer pointedly noted last month that the company did not receive any money from Operation Warp Speed to develop its Covid-19 vaccine with BioNTech. That launched a verbal back-and-forth with President Donald Trump, who continued to insist Pfizer was indeed part of the program.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.